The Cancer Research Institute (CRI), the Association for Cancer lmmunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to join forces once again to sponsor the Fourth International Cancer lmmunotherapy Conference.

The 2018 meeting will take place at the New York Marriott Marquis in New York, New York, USA from September 30-October 3, 2018. The program will focus on "Translating Science into Survival," and feature talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including: regulating T cells and their response to cancer, tumor microenvironment, genetically engineered T cells, maintenance of immune balance, novel vaccine platforms and combinations, mutational analysis and predicing response to immunotherapy, convergence of technology and cancer immunotherapy, microbiome and metabolism.  This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.


pending AACR review

PLanning Committee Members

Conference Co-Chairpersons

  • Nina Bhardwaj, Icahn School of Medicine at Mt. Sinai, New York, NY
  • Christoph Huber, Association for Cancer Immunotherapy (CIMT), Mainz, Germany
  • Elizabeth M. Jaffee, Johns Hopkins School of Medicine, Baltimore, MD
  • Guido Kroemer, Centre de Recherche des Cordeliers, Paris, France

scientific planning committee

  • Carl G. Figdor, Radboud University Nijmegen, Nijmegen, The Netherlands
  • Wolf H. Fridman, Centre de Recherche des Cordeliers, Paris, France
  • Crystal L. Mackall, Stanford University School of Medicine, Stanford, CA
  • Cornelis J. M. Melief, Leiden University Medical Center & ISA Pharmaceuticals, Leiden, The Netherlands
  • Drew M. Pardoll, Johns Hopkins School of Medicine, Baltimore, MD
  • Ellen Puré, University of Pennsylvania, Philadelphia, PA
  • Catherine Sautès-Fridman, Université Paris-Descartes, Paris, France
  • Ton Schumacher, The Netherlands Cancer Institute, Leiden, The Netherlands
  • Giorgio Trinchieri, National Cancer Institute, Bethesda, MD
  • Özlem Türeci, Ganymed Pharmaceuticals, Mainz, Germany
  • Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY
  • Laurence Zitvogel, Institut Gustave Roussy, Paris, France